High-dose dexamethasone therapy as the initial treatment for idiopathic thrombocytopenic purpura

There is a controversy which short term high dose dexamethasone therapy (HDD) or standard dose prednisolone therapy as the initial treatment leads to long term efficacy in idiopathic thrombocytopenic purpura (ITP) patients. We conducted a multicenter, prospective trial to determine the efficacy and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of hematology 2020-03, Vol.111 (3), p.388-395
Hauptverfasser: Takase, Ken, Nagai, Hirokazu, Kadono, Moe, Yoshioka, Takanori, Yoshio, Nobuyuki, Hirabayashi, Yukio, Ito, Takuo, Sawamura, Morio, Yokoyama, Akihiro, Yoshida, Shinichiro, Tsutsumi, Ikuyo, Otsuka, Maki, Suehiro, Youko, Hidaka, Michihiro, Yoshida, Isao, Yokoyama, Hisayuki, Inoue, Hitoshi, Iida, Hiroatsu, Nakayama, Maki, Hishita, Terutoshi, Iwasaki, Hiromi, Kada, Akiko, Saito, Akiko M., Kuroda, Yoshiaki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:There is a controversy which short term high dose dexamethasone therapy (HDD) or standard dose prednisolone therapy as the initial treatment leads to long term efficacy in idiopathic thrombocytopenic purpura (ITP) patients. We conducted a multicenter, prospective trial to determine the efficacy and safety of short-term HDD in ITP patients aged 18–80 years with platelet counts of
ISSN:0925-5710
1865-3774
DOI:10.1007/s12185-019-02808-6